540359 PARMAX

Parmax Pharma Share PriceParmax Pharma

₹30.61
-0.12 (-0.39%)
As on 09 December, 2023 | 01:55 BSE: 540359 NSE: PARMAXISIN: INE240T01014

Parmax Pharma Performance

Day Range

  • Low
  • High
₹ 30.61

52 Week Range

  • Low
  • High
₹ 30.61
  • Open Price
  • Previous Close
  • Volume

Start SIP in Parmax Pharma

Start SIP

Parmax Pharma Share Price

  • Over 1 Month -0.49%
  • Over 3 Month 2.03%
  • Over 6 Month -0.75%
  • Over 1 Year -17.27%

Parmax Pharma Key Statistics

Parmax Pharma Investment Rating

  • Master Rating:
  • Parmax Pharma has an operating revenue of Rs. 17.20 Cr. on a trailing 12-month basis. An annual revenue de-growth of -16% needs improvement, Pre-tax margin of 0% needs improvement, ROE of -1% is poor and needs improvement. The company has a debt to equity of 76%, which is bit higher. From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 19 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C+ which is evident from recent supply seen, Group Rank of 74 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

EPS Strength

N/A

Price Strength

Buyer Demand

Group Rank

Parmax Pharma Financials
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 4165227
Operating Expenses Qtr Cr 5263226
Operating Profit Qtr Cr -1-1120-11
Depreciation Qtr Cr 0000000
Interest Qtr Cr 0000000
Tax Qtr Cr 0000000
Net Profit Qtr Cr -1-102-1-10
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 1518
Operating Expenses Annual Cr 1316
Operating Profit Annual in Cr 23
Depreciation Cr 22
Interest Annual Cr 00
Tax Annual Cr 00
Net Profit Annual Cr 00
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 11
Cash from Investing Activity Annual Cr -2-2
Cash from Financing Annual Activity Cr -1-1
Net Cash Flow Annual Cr -2
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 66
Fixed Assets Annual Cr 1010
Total Non Current Assets Annual Cr 1011
Total Current Assets Annual Cr 87
Total Assets Annual Cr 1818
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 1313
ROE Annual % -22
ROCE Annual % 46
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 1514
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr
Operating Expenses Qtr Cr
Operating Profit Qtr Cr
Depreciation Qtr Cr
Interest Qtr Cr
Tax Qtr Cr
Net Profit Qtr Cr
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr
Operating Expenses Annual Cr
Operating Profit Annual in Cr
Depreciation Cr
Interest Annual Cr
Tax Annual Cr
Net Profit Annual Cr
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr
Cash from Investing Activity Annual Cr
Cash from Financing Annual Activity Cr
Net Cash Flow Annual Cr
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr
Fixed Assets Annual Cr
Total Non Current Assets Annual Cr
Total Current Assets Annual Cr
Total Assets Annual Cr
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs
ROE Annual %
ROCE Annual %
Total Debt to Total Equity Annual --
EBDIT Annual Margin %

Parmax Pharma Technicals

EMA & SMA

Current Price
₹30.61
-0.12 (-0.39%)
pointer
  • Bullish Moving Average
  • ___
  • 2
  • Bearish Moving Average
  • ___
  • 14
  • 20 Day
  • ₹30.83
  • 50 Day
  • ₹30.67
  • 100 Day
  • ₹30.66
  • 200 Day
  • ₹31.49
  • 20 Day
  • ₹31.02
  • 50 Day
  • ₹30.62
  • 100 Day
  • ₹30.40
  • 200 Day
  • ₹30.80

Parmax Pharma Resistance and Support

PIVOT
₹30.9
Resistance
First Resistance 31.60
Second Resistance 32.59
Third Resistance 33.29
RSI 48.77
MFI 47.34
MACD Single Line 0.13
MACD 0.05
Support
First Resistance 29.91
Second Resistance 29.21
Third Resistance 28.22

Parmax Pharma Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 1,989 155,699 78.28
Week 1,118 96,741 86.53
1 Month 1,580 136,583 86.45
6 Month 1,278 105,678 82.71

Parmax Pharma Result Highlights

Parmax Pharma Synopsis

BSE-Medical-Diversified

Parmax Pharma is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 18.25 Cr. and Equity Capital is Rs. 4.45 Cr. for the Year ended 31/03/2022. Parmax Pharma Ltd. is a Public Limited Listed company incorporated on 02/11/1994 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24231GJ1994PLC023504 and registration number is 023504.
Market Cap 11
Sales 17
Shares in Float 0.26
No of funds
Yield
Book Value 2.33
U/D Vol ratio 0.9
LTDebt / Equity 76
Alpha 0.07
Beta -0.56

Parmax Pharma

Owner NameSep-23Jun-23Mar-23Dec-22
Promoters 30.8%30.8%30.8%30.8%
Individual Investors 65.43%65.42%65.38%65.36%
Others 3.77%3.78%3.82%3.84%

Parmax Pharma Management

Name Designation
Mr. Umang Alkesh Gosalia Managing Director
Mr. Pramay A Chhatra Independent Director
Ms. Ami R Shah Independent Director

Parmax Pharma Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Parmax Pharma Corporate Action

Date Purpose Remarks
2023-11-10 Quarterly Results
2023-08-14 Quarterly Results
2023-05-30 Audited Results
2023-02-11 Quarterly Results
2022-11-12 Quarterly Results

Parmax Pharma FAQs

What is Share Price of Parmax Pharma ?

Parmax Pharma share price is ₹30 As on 09 December, 2023 | 01:41

What is the Market Cap of Parmax Pharma ?

The Market Cap of Parmax Pharma is ₹11.5 Cr As on 09 December, 2023 | 01:41

What is the P/E ratio of Parmax Pharma ?

The P/E ratio of Parmax Pharma is -18.2 As on 09 December, 2023 | 01:41

What is the PB ratio of Parmax Pharma ?

The PB ratio of Parmax Pharma is 2 As on 09 December, 2023 | 01:41

Q2FY23